glp-1 gastroparesis treatment receptor agonists and delayed gastric emptying: implications for invasive cardiac interventions and surgery Researchers find GLP-1 medications safe

PlexusDx explains the mechanisms behind delayed gastrointestinal symptoms and offers genetic testing to predict individual tolerance patterns

2015;14:73

Agents such as dulaglutide, liraglutide, semaglutide, and tirzepatide differ in pharmacology and dosing, directly influencing perioperative safety, particularly due to their effects on gastric motility and the high frequency of gastrointestinal (GI) adverse events that raise concerns about aspiration and postoperative morbidity in urgent or elective procedures

For instance, in Texas, which is among the top 10 state obesity rates in the

Low dose GLP-1 medication prescribed online through Mochi Health.

The outcomes were changes in weight, body mass index (BMI), waist circumference (WC), glycemia, blood pressure, and lipid profiles